{
    "status": "ok",
    "totalResults": 1,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "GlobeNewswire",
            "title": "PROCEPT BioRobotics\u00ae Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation\u00ae Therapy for Prostate Cancer",
            "description": "(marketscreener.com) REDWOOD CITY, Calif., Sept. 12, 2023 -- PROCEPT BioRobotics Corporation , a global leader in surgical robotics, announced today the Investigational Device Exemption approval from the U.S. Food and Drug Administration to investigate the sa\u2026",
            "url": "https://www.marketscreener.com/quote/stock/PROCEPT-BIOROBOTICS-CORPO-126986326/news/PROCEPT-BioRobotics-Receives-U-S-FDA-Investigational-Device-Exemption-to-Investigate-Aquablation-44823159/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-12T12:02:02Z",
            "content": "REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (PROCEPT BioRobotics), a global leader in surgical robotics, announced today the Investigationa\u2026 [+7266 chars]"
        }
    ]
}